Internal Medicine · Oklahoma City, OK
NPI
1861753287
Since 2012
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
608 NW 9th St, Suite 3110 & 4106
Oklahoma City, OK, 73102
Phone (405) 272-5433
Groups this clinician bills Medicare through
Medicare paid, 2024
$179K
2,907 services
Medicare patients, 2024
632
Average age 75
Drug cost, 2024
$1.0M
10,533 prescriptions
Company payments, 2025
$1,272
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew B Austin was code 99214 (office e&m - established), 1,161 times for 558 patients. In total Matthew B Austin billed 2,907 services in 68 codes, and Medicare paid $179K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-06-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,161 | 558 | $79.19 | $92K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 383 | 276 | $11.76 | $4,502 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 341 | 341 | $119.80 | $41K |
| G0008 Administration of influenza virus vaccine | Office | 111 | 108 | $30.07 | $3,338 |
| 90662 Vaccine Product | Office | 105 | 102 | $80.97 | $8,502 |
| 96372 Injection Administration | Office | 74 | 31 | $9.60 | $710 |
| 99213 Office E&M - Established | Office | 51 | 49 | $54.13 | $2,761 |
| 71046 X-ray - Chest | Office | 41 | 38 | $13.03 | $534 |
| G0009 Administration of pneumococcal vaccine | Office | 39 | 39 | $30.07 | $1,173 |
| 90677 Vaccine Product | Office | 39 | 39 | $289.25 | $11K |
| 99204 Office E&M - New | Office | 33 | 33 | $89.85 | $2,965 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 30 | 17 | $0.86 | $25.89 |
| 83036 Blood Count | Office | 30 | 27 | $9.52 | $286 |
| 72100 X-ray - Spine and Pelvis | Office | 25 | 25 | $17.96 | $449 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 21 | 19 | $37.34 | $784 |
By year: 2022 $171K for 3,139 services; 2023 $203K for 2,787 services; 2024 $179K for 2,907 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 30 | 27 | $9.52 | $286 |
| 81003 Clinical Chemistry | 19 | 18 | $2.20 | $41.8 |
Medicare prescription drug claims, 2024
In 2024, the drug Matthew B Austin prescribed most often to Medicare patients was Atorvastatin Calcium, with 688 prescriptions and refills. In total Matthew B Austin wrote 10,533 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 688 | 1,928 | 196 | $14K |
| Levothyroxine Sodium Generic | 435 | 1,178 | 126 | $4,984 |
| Amlodipine Besylate Generic | 334 | 951 | 107 | $3,636 |
| Omeprazole Generic | 325 | 847 | 100 | $6,459 |
| Rosuvastatin Calcium Generic | 317 | 923 | 103 | $5,153 |
| Losartan Potassium Generic | 283 | 795 | 87 | $4,372 |
| Lisinopril Generic | 267 | 771 | 92 | $1,926 |
| Gabapentin Generic | 262 | 625 | 82 | $5,697 |
| Pantoprazole Sodium Generic | 251 | 672 | 72 | $6,084 |
| Hydrochlorothiazide Generic | 245 | 659 | 76 | $923 |
| Trazodone Hcl Generic | 213 | 544 | 62 | $1,937 |
| Montelukast Sodium Generic | 191 | 510 | 64 | $4,437 |
| Simvastatin Generic | 172 | 488 | 53 | $2,018 |
| Sertraline Hcl Generic | 167 | 457 | 55 | $2,045 |
| Olmesartan Medoxomil Generic | 153 | 446 | 44 | $3,210 |
Brand drugs: 1,291 claims; generic drugs: 9,180 claims; opioid claims: 131.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew B Austin $1,272 ($1,272 in general payments such as food, travel and fees) from 18 companies. The largest payer was Pfizer Inc. with $267.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 17 | $267 |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $245 |
| Abbott Laboratories ABT | 13 | $203 |
| Abbvie Inc. ABBV | 14 | $171 |
| Madrigal Pharmaceuticals MDGL | 2 | $56.32 |
| Exact Sciences Corporation EXAS | 3 | $42.55 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $37.29 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $32.63 |
| Sanofi Pasteur Inc. SNY | 2 | $31.89 |
| Phathom Pharmaceuticals, Inc. PHAT | 3 | $28.2 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.